Ticker Hub
TNXP — AI Analysis & Sentiment
4 recent AI-generated analyses for TNXP. Sentiment and confidence insights updated continuously.
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Tonix Pharmaceuticals' announcement of positive early clinical data for its Lyme disease and orthopox candidates validates pipeline progress. This ...
Mar 23, 2026Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Tonix Pharmaceuticals' recent earnings show substantial financial weakness with increased losses and extreme shareholder dilution. This significant...
Mar 12, 2026Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
Tonix Pharmaceuticals published clinical data confirming FDA approval for TONMYA™, a new fibromyalgia treatment. This strengthens its market positi...
Mar 5, 2026Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market
Tonix Pharmaceuticals announced its uplisting to the Nasdaq Global Select Market, which could improve its visibility and liquidity. This is signifi...
Mar 3, 2026